Preventive Oncology for the Gynecologist

Dr Sumita Mehta is a specialist and heads the department of obstetrics & gynecology at Babu Jagjivan Ram Memorial Hospital, Delhi. She is a graduate of Lady Hardinge Medical College, Delhi, and received her diplomate national board of examinations (obstetrics & gynecology) from Sir Ganga Ram hospital, Delhi. She has edited eight books, published numerous articles, and delivered many guest lectures. She is also a reviewer for many international journals. She has previously served as secretary of the Indian Society of Colposcopy and Cervical Pathology (ISCCP) and as an executive member and editor for the Association of Obstetricians & Gynecologists of Delhi. She is the state resource person for training of doctors in preventive oncology under the Delhi Govt. Health Scheme and a National Expert for project ECHO (Extension for Community Healthcare Outcomes) at the National Institute of Cancer Prevention & Research, Delhi. She is also an IFCPC (International Federation of Cervical Pathology & Colposcopy)-IARC (International Agency for Research on Cancer) certified National Trainer for colposcopy. Her primary area of interest is gynecologic oncology.Dr. Anshuja Singla is assistant professor in the department of obstetrics & gynaecology at University College of Medical Sciences and Guru Teg Bahadur Hospital, Delhi. She is actively involved in departmental academic and administrative work. Her areas of interest are infertility and gynecologic endoscopy. She has many publications.

• HPV epidemiology in prevention of cervical cancer.- Cytology versus HPV testing for primary prevention.- Methods of HPV testing: clinical implications.- Novel biomarkers for HPV detection.- Colposcopic principles & tissue basis.- Colposcopic features of cervical intraepithelial lesions.- HPV vaccines.- Cervical cancer screening in pregnancy.- Cervical cancer screening in low resource settings.- Ablative methods for treatment of intraepithelial lesions.- CIN 2 lesions: management dilemmas.- Follow up after treatment of CIN.- Epidemiology/Risk factors of endometrial cancers.- Role of cytology.- Hysteroscopy and cancer prevention.- Premalignant lesions of endometrium? Endometrial hyperplasia.- Hereditary endometrial cancers & prevention.- Chemoprevention of endometrial cancers.- Ovarian malignancy: risk factors.- Role of tumor markers.- Sonographic screening.- Role of prophylactic surgery/oophorectomy.- Risk factors for breast malignancy.- Role of breast examination/CBE.- Facts aboutmammography.- Cancer risk & genetic testing.- What’s new in breast screening.- Classification of vulval lesions.- Vulvoscopy: the way forward.- Vulval intraepithelial lesions(VIN): diagnosis & management.- Vaginal intraepithelial lesions(VAIN).- Screening guidelines for cervical cancer.- Screening guidelines for endometrial cancer.- Recommendations for ovarian cancer screening.- Breast cancer screening strategies.- Case discussions on various scenarios of different premalignant conditions of cervix, endometrium, breast & ovary.